Analyst Ratings for Cellectar Biosciences (CLRB)
CLRB Rating Summary
CLRB Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$11.50 (+908.8%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 87%
Avg. $ Target:
$11.50 (+908.8%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 87%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/13/2026 | Brookline Capital Markets | Kumaraguru Raja | New Coverage | Buy (N/A) |
15.00 (N/A) |
2.77 (1.14) |
-58.84% | Details |
| 5/15/2026 | Ladenburg Thalmann | Kevin DeGeeter | New Coverage | Buy (N/A) |
10.00 (N/A) |
3.20 (1.14) |
-64.38% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
